Table 4.

Summary of clinical data on study patients by FLT3 mutation status


Characteristics

ITD, N = 15

PM, N = 15

WT, N = 14

P
Median age, y   12.6   9.4   7.2   .2820  
Median WBCs per 103/mm3  90.0   13.3   30.1   .0190* 
Cytogenetics, no. patients (%)     
    Favorable [t(8;21), inv(16), t(16;16), del(16)]   2 (13)   3 (20)   2 (14)   .8652  
    Intermediate [nl, aneuploid, +8, abn(11q23)]   5 (33)   8 (53)   6 (43)   .5424  
    Adverse [-5, del(5q), -7, abn(3q)]   0 (0)   0 (0)   0 (0)   NA  
    Not available   8 (53)   4 (27)   6 (43)   .3265  
FAB classification, no. patients (%)     
    M0   0 (0)   2 (13)   1 (17)   .3496  
    M1   2 (13)   3 (20)   1 (7)   .601  
    M2   7 (47)   3 (20)   2 (14)   .1089  
    M4   4 (27)   3 (20)   3 (21)   .9005  
    M5   2 (13)   4 (27)   6 (43)   .2033  
    M7   0 (0)   0 (0)   1 (7)   .3341  
Percent induction CR   79%   87%   86%   .8152  
Overall survival from DX at 5 years   15%   67%   76%   .0018* 
Relapse-free survival from CR at 5 years
 
20%
 
58%
 
73%
 
.0059*
 

Characteristics

ITD, N = 15

PM, N = 15

WT, N = 14

P
Median age, y   12.6   9.4   7.2   .2820  
Median WBCs per 103/mm3  90.0   13.3   30.1   .0190* 
Cytogenetics, no. patients (%)     
    Favorable [t(8;21), inv(16), t(16;16), del(16)]   2 (13)   3 (20)   2 (14)   .8652  
    Intermediate [nl, aneuploid, +8, abn(11q23)]   5 (33)   8 (53)   6 (43)   .5424  
    Adverse [-5, del(5q), -7, abn(3q)]   0 (0)   0 (0)   0 (0)   NA  
    Not available   8 (53)   4 (27)   6 (43)   .3265  
FAB classification, no. patients (%)     
    M0   0 (0)   2 (13)   1 (17)   .3496  
    M1   2 (13)   3 (20)   1 (7)   .601  
    M2   7 (47)   3 (20)   2 (14)   .1089  
    M4   4 (27)   3 (20)   3 (21)   .9005  
    M5   2 (13)   4 (27)   6 (43)   .2033  
    M7   0 (0)   0 (0)   1 (7)   .3341  
Percent induction CR   79%   87%   86%   .8152  
Overall survival from DX at 5 years   15%   67%   76%   .0018* 
Relapse-free survival from CR at 5 years
 
20%
 
58%
 
73%
 
.0059*
 

WBC indicates white blood cells; FAB, French-American-British; CR, complete remission; DX, diagnosis; and NA, not available.

*

Indicates statistically significant.

Close Modal

or Create an Account

Close Modal
Close Modal